Omnicell - Public Comps and Valuation Multiples

Omnicell Overview

About Omnicell

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Founded

1992

HQ

Employees

3.7K+

Website

omnicell.com

Sectors

Healthcare Software
Pharmacies
B2B SaaS
Vertical SaaS
HealthTech

Financials

LTM Revenue $1.1B

LTM EBITDA $134M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Omnicell Financials

As of September 2025, Omnicell reported last 12-month revenue of $1.1B and EBITDA of $134M.

In the same period, Omnicell generated $493M in LTM gross profit and $74.6M in net income.

See Omnicell valuation multiples based on analyst estimates

Omnicell P&L

In the most recent fiscal year, Omnicell reported revenue of $1.1B and EBITDA of $90.1M.

Omnicell expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Omnicell valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.1B	XXX	$1.1B	XXX	XXX	XXX
Gross Profit	$493M	XXX	$471M	XXX	XXX	XXX
Gross Margin	43%	XXX	42%	XXX	XXX	XXX
EBITDA	$134M	XXX	$90.1M	XXX	XXX	XXX
EBITDA Margin	12%	XXX	8%	XXX	XXX	XXX
EBIT	$77.2M	XXX	$0.3M	XXX	XXX	XXX
EBIT Margin	7%	XXX	0%	XXX	XXX	XXX
Net Profit	$74.6M	XXX	$12.5M	XXX	XXX	XXX
Net Margin	7%	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Omnicell including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.1B. EBITDA for the last twelve months was $134M. In the most recent fiscal year, Omnicell achieved $1.1B in revenue and $90.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.1B	Analyst estimates available to subscribers	$1.1B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$493M	Analyst estimates available to subscribers	$471M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	43.1% gross margin	Analyst estimates available to subscribers	42.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$134M	Analyst estimates available to subscribers	$90.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	11.8% EBITDA margin	Analyst estimates available to subscribers	8.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$77.2M	Analyst estimates available to subscribers	$0.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	6.8% EBIT margin	Analyst estimates available to subscribers	0.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$74.6M	Analyst estimates available to subscribers	$12.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	6.5% net profit margin	Analyst estimates available to subscribers	1.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Omnicell

This financial data table provides comprehensive performance metrics for Omnicell, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Omnicell generated $1.1B in revenue over the last twelve months.
The company achieved $134M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $493M.
Net income over the last twelve months reached $74.6M.

Fiscal Year Performance

In the most recent fiscal year, Omnicell reported $1.1B in total revenue.
Fiscal year EBITDA was $90.1M.
The company maintained a gross profit margin of 42.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 8.1%.
Net profit margin reached 1.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Omnicell. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Omnicell Stock Performance

Omnicell has current market cap of $1.4B, and EV of $1.3B.

Market Cap Evolution

Omnicell Stock Data

As of October 17, 2025, Omnicell's stock price is $30.

See Omnicell trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$1.4B	XXX	XXX	XXX	XXX	$1.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Omnicell Valuation Multiples

Omnicell's trades at 1.2x EV/Revenue multiple, and 14.9x EV/EBITDA.

See valuation multiples for Omnicell and 15K+ public comps

Omnicell Financial Valuation Multiples

As of October 17, 2025, Omnicell has market cap of $1.4B and EV of $1.3B.

Equity research analysts estimate Omnicell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Omnicell has a P/E ratio of 18.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	1.2x	XXX	XXX	XXX
EV/EBITDA	10.0x	XXX	14.9x	XXX	XXX	XXX
EV/EBIT	17.4x	XXX	3994.7x	XXX	XXX	XXX
EV/Gross Profit	2.7x	XXX	n/a	XXX	XXX	XXX
P/E	18.4x	XXX	109.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	10.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Omnicell Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Omnicell Margins & Growth Rates

Omnicell's last 12 month revenue growth is 4%

Omnicell's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Omnicell's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Omnicell's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Omnicell and other 15K+ public comps

Omnicell Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	4%	XXX	4%	XXX	XXX	XXX
EBITDA Margin	12%	XXX	8%	XXX	XXX	XXX
EBITDA Growth	8%	XXX	49%	XXX	XXX	XXX
Rule of 40	9%	XXX	12%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	21%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	42%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial